Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEPOLIZUMAB Cause Mycobacterium avium complex infection? 58 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Mycobacterium avium complex infection have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.1% of all adverse event reports for MEPOLIZUMAB.

58
Reports of Mycobacterium avium complex infection with MEPOLIZUMAB
0.1%
of all MEPOLIZUMAB reports
1
Deaths
10
Hospitalizations

How Dangerous Is Mycobacterium avium complex infection From MEPOLIZUMAB?

Of the 58 reports, 1 (1.7%) resulted in death, 10 (17.2%) required hospitalization.

Is Mycobacterium avium complex infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 58 reports have been filed with the FAERS database.

What Other Side Effects Does MEPOLIZUMAB Cause?

Asthma (11,033) Dyspnoea (9,192) Wheezing (6,093) Product dose omission issue (5,873) Cough (4,577) Pneumonia (4,107) Therapeutic product effect incomplete (4,106) Drug ineffective (3,880) Loss of personal independence in daily activities (3,566) Fatigue (2,656)

What Other Drugs Cause Mycobacterium avium complex infection?

PREDNISONE (300) AMIKACIN (274) ETHAMBUTOL (228) TACROLIMUS (164) RIFAMPIN (152) AZITHROMYCIN (143) METHOTREXATE (127) MYCOPHENOLATE MOFETIL (124) ALBUTEROL (121) TIOTROPIUM (117)

Which MEPOLIZUMAB Alternatives Have Lower Mycobacterium avium complex infection Risk?

MEPOLIZUMAB vs MEPROBAMATE MEPOLIZUMAB vs MERCAPTOPURINE MEPOLIZUMAB vs MEROPENEM MEPOLIZUMAB vs MEROPENEM ANHYDROUS MEPOLIZUMAB vs MESALAMINE

Related Pages

MEPOLIZUMAB Full Profile All Mycobacterium avium complex infection Reports All Drugs Causing Mycobacterium avium complex infection MEPOLIZUMAB Demographics